Mone Zaidi is the editor of Skeletal Development and Remodeling in Health, Disease and Aging, Volume 1068, published by Wiley.

• Part I: Skeletal Development:. 1. PTHrP and Skeletal Development: Henry Kronenberg.2. Regulating Bone Growth with BMPs: Phoebe Leboy.3. BMP and BMP Inhibitors in Bone: Vicki Rosen.4. BMP Signaling and Skeletalogensis: Xu Cao.5. Function of BMP and BMP Antagonist in Adult Bone: Etsuko Abe.6. Dysregulation of the BMP4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva: Frederick Kaplan.7. Hypoxia, HIF-1ƒÑ and VHL in Chondrogenesis: Ernestina Schipani.8. Cellular and Molecular Mechanisms of Synovial Joint and Articular Cartilage Formation: Maurizio Pacifici.9. Multiple Roles of Hoxc8 in Skeletal Development: Aster Juan et al.Part II: Skeletal Remodeling:.10. Osteoclasts and Integrins: Steven Teitelbaum.11. Regulation of Osteoclast Differentiation: David Roodman.12. Signaling in Osteoclast and their Precursors: Patrick Ross.13. Canonical Wnt Signaling in Osteoblasts is Required for Osteoclast Differentiation: Gerard Karsenty.14. Inhibition of ATF4 Transcriptional Activity by TIAT/ƒ×-Taxilin Modulates Bone Mass: Rene St. Arnaud.15. Paget's Disease of Bone and Genetic Disorders of RANK/OPG/RANK/NF-ƒÛB signaling: Michael Whyte.16. The Regulation of Cathepsin K Gene Expression: Bruce Troen.17. Direct and Indirect Estrogen Actions on Osteoblasts and Osteoclasts: Alberta Zallone.18. Molecular Mechanism of the Life and Death of the Osteoclast: Sakae Tanaka.19. Understanding Parathyroid Hormone Action: Nicola Partridge.20. New Insights Into the Mechanisms Involved in The Pleiotropic Actions of 1,25dihydroxyvitamin D3: Sylvia Christakos.21. Mechanisms of Vitamin D Receptor Action: Marie Demay.22. Role of Connexin 43 in Osteoblast Response to Physical Load: Roberto Civitelli.23. Interactive Effect of Interleukin-6 and Prostaglandin E2 on Osteoclastogenesis via the OPG/RANK-L/RANK System: Xin-Hua Liu.24. Does TNF Have Anti-Osteoclastogenic Actions?: Jameel Iqbal.25. Eosinophil Chemotactic Factor-L (ECF-L) Enhances Osteoclast Formation by Increasing ICAM-1 Expression: Garcia Palacios and David Roodman.Part III: Mechanisms Of Bone Loss:.26. Bone Cell Precursors and the Pathophysiology of Bone Loss: Harry Blair and Jill Carrington.27. Autosomal Dominant Pseudohypoparathyroidism Type 1b is Caused by Different Microdeletions Within or Upstream of the GNAS Locus: Harold Jueppner.28. Estrogen Regulation of Immune Cells Bone Interactions: Roberto Pacifici.29. Autoimmunity and Bone: Edward Schwarz.30. Non-Steroid Immune Modulators and Bone Disease: Solomon Epstein.31. Pathogenesis of Osteopenia/Osteoporosis Induced by Highly Active Anti-Retroviral Therapy for AIDS: Jay McDonald.32. Pituitary Hormones and Bone Loss: Mone Zaidi.33. Bone Destruction in Multiple Myeloma: Toshio Matsumoto.34. Osteogenic Regulation of Vascular Calcification: Dwight Towler.35. The OPG/TRAIL Complex in an In Vitro Osteoclastogenesis Model Dervied From Human Multiple Myeloma Bone Disease: Maria Grano et al.36. Restoration of Bone Mass in hpg Mouse by Preoptic Area Grafting: Gopalan Rajendren.37. IL-7 Drives T Cell-Medicated Bone Loss Following Ovariectomy: Michaela Robbie-Ryan and M. Neale Weitzmann.Part IV: Restoring Skeletal Strength:.38. Stem Cells and Tissue Engineering: Past, Present and Future: Julia Polak.39. Bisphosphonates: From Bench to Bedside: Graham Russell.40. Novel Targets and Therapeutics for Bone Loss: Ronald N. Margolis and Sunil J. Wimalawansa.41. Advanced Imaging Assessment of Bone Quality: Harry Genant.42. Bone Strength: Current Concepts: Charles Turner.43. Anti-Catabolic Therapeutic Target in Bone Disease: Brendan Boyce.44. Mechanisms Involved in Skeleton Anabolic Therapies: Jack Martin.45. Misconceptions About Calcimimetics: Edward Nemeth.46. Osteoblastic Activation in the Hematopoetic Stem Cell Niche: Laura Calvi.47. Circulating Cells with Osteogenic Potential: Sundeep Khosla.48. The Pericellular Matrix as a Transducer of Biomechanical Signals in Auricular Cartilage: Farshid Guilak.49. Clinical Biophysics: The Promotion of Skeletal Repair by Physical Force: Roy Aaron.50. COX-2 has a Critical Role During Incorporation of Structural Bone Allografts: Regis O'Keefe.51. The Effect of Anti-TNF Therapy on Spinal Bone Mineral Density in Crohn¡¦s Disease: Michael Pazianas.52. Bone Remodeling in Health and Disease: Lessons from Mathematical Modeling: Svetlana V Komarova.53. Modeling of Serum C-Telopeptide Levels with Daily and Monthly Oral Ibandronate: Mone Zaidi.54. NFATc1: A Novel Anabolic Therapeutic Target for Osteoporosis: Majd Zayzafoon.55. Mechanical Loading Differentially Regulates Membrane Bound and Soluble RANKL Availability in MC3T3-E1 Cells: Dae Won Kim and Francis Y. Lee.Index of Contributors

Mone Zaidi is the editor of Skeletal Development and Remodeling in Health, Disease and Aging, Volume 1068, published by Wiley.

• Part I: Skeletal Development:. 1. PTHrP and Skeletal Development: Henry Kronenberg.2. Regulating Bone Growth with BMPs: Phoebe Leboy.3. BMP and BMP Inhibitors in Bone: Vicki Rosen.4. BMP Signaling and Skeletalogensis: Xu Cao.5. Function of BMP and BMP Antagonist in Adult Bone: Etsuko Abe.6. Dysregulation of the BMP4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva: Frederick Kaplan.7. Hypoxia, HIF-1ƒÑ and VHL in Chondrogenesis: Ernestina Schipani.8. Cellular and Molecular Mechanisms of Synovial Joint and Articular Cartilage Formation: Maurizio Pacifici.9. Multiple Roles of Hoxc8 in Skeletal Development: Aster Juan et al.Part II: Skeletal Remodeling:.10. Osteoclasts and Integrins: Steven Teitelbaum.11. Regulation of Osteoclast Differentiation: David Roodman.12. Signaling in Osteoclast and their Precursors: Patrick Ross.13. Canonical Wnt Signaling in Osteoblasts is Required for Osteoclast Differentiation: Gerard Karsenty.14. Inhibition of ATF4 Transcriptional Activity by TIAT/ƒ×-Taxilin Modulates Bone Mass: Rene St. Arnaud.15. Paget's Disease of Bone and Genetic Disorders of RANK/OPG/RANK/NF-ƒÛB signaling: Michael Whyte.16. The Regulation of Cathepsin K Gene Expression: Bruce Troen.17. Direct and Indirect Estrogen Actions on Osteoblasts and Osteoclasts: Alberta Zallone.18. Molecular Mechanism of the Life and Death of the Osteoclast: Sakae Tanaka.19. Understanding Parathyroid Hormone Action: Nicola Partridge.20. New Insights Into the Mechanisms Involved in The Pleiotropic Actions of 1,25dihydroxyvitamin D3: Sylvia Christakos.21. Mechanisms of Vitamin D Receptor Action: Marie Demay.22. Role of Connexin 43 in Osteoblast Response to Physical Load: Roberto Civitelli.23. Interactive Effect of Interleukin-6 and Prostaglandin E2 on Osteoclastogenesis via the OPG/RANK-L/RANK System: Xin-Hua Liu.24. Does TNF Have Anti-Osteoclastogenic Actions?: Jameel Iqbal.25. Eosinophil Chemotactic Factor-L (ECF-L) Enhances Osteoclast Formation by Increasing ICAM-1 Expression: Garcia Palacios and David Roodman.Part III: Mechanisms Of Bone Loss:.26. Bone Cell Precursors and the Pathophysiology of Bone Loss: Harry Blair and Jill Carrington.27. Autosomal Dominant Pseudohypoparathyroidism Type 1b is Caused by Different Microdeletions Within or Upstream of the GNAS Locus: Harold Jueppner.28. Estrogen Regulation of Immune Cells Bone Interactions: Roberto Pacifici.29. Autoimmunity and Bone: Edward Schwarz.30. Non-Steroid Immune Modulators and Bone Disease: Solomon Epstein.31. Pathogenesis of Osteopenia/Osteoporosis Induced by Highly Active Anti-Retroviral Therapy for AIDS: Jay McDonald.32. Pituitary Hormones and Bone Loss: Mone Zaidi.33. Bone Destruction in Multiple Myeloma: Toshio Matsumoto.34. Osteogenic Regulation of Vascular Calcification: Dwight Towler.35. The OPG/TRAIL Complex in an In Vitro Osteoclastogenesis Model Dervied From Human Multiple Myeloma Bone Disease: Maria Grano et al.36. Restoration of Bone Mass in hpg Mouse by Preoptic Area Grafting: Gopalan Rajendren.37. IL-7 Drives T Cell-Medicated Bone Loss Following Ovariectomy: Michaela Robbie-Ryan and M. Neale Weitzmann.Part IV: Restoring Skeletal Strength:.38. Stem Cells and Tissue Engineering: Past, Present and Future: Julia Polak.39. Bisphosphonates: From Bench to Bedside: Graham Russell.40. Novel Targets and Therapeutics for Bone Loss: Ronald N. Margolis and Sunil J. Wimalawansa.41. Advanced Imaging Assessment of Bone Quality: Harry Genant.42. Bone Strength: Current Concepts: Charles Turner.43. Anti-Catabolic Therapeutic Target in Bone Disease: Brendan Boyce.44. Mechanisms Involved in Skeleton Anabolic Therapies: Jack Martin.45. Misconceptions About Calcimimetics: Edward Nemeth.46. Osteoblastic Activation in the Hematopoetic Stem Cell Niche: Laura Calvi.47. Circulating Cells with Osteogenic Potential: Sundeep Khosla.48. The Pericellular Matrix as a Transducer of Biomechanical Signals in Auricular Cartilage: Farshid Guilak.49. Clinical Biophysics: The Promotion of Skeletal Repair by Physical Force: Roy Aaron.50. COX-2 has a Critical Role During Incorporation of Structural Bone Allografts: Regis O'Keefe.51. The Effect of Anti-TNF Therapy on Spinal Bone Mineral Density in Crohn¡¦s Disease: Michael Pazianas.52. Bone Remodeling in Health and Disease: Lessons from Mathematical Modeling: Svetlana V Komarova.53. Modeling of Serum C-Telopeptide Levels with Daily and Monthly Oral Ibandronate: Mone Zaidi.54. NFATc1: A Novel Anabolic Therapeutic Target for Osteoporosis: Majd Zayzafoon.55. Mechanical Loading Differentially Regulates Membrane Bound and Soluble RANKL Availability in MC3T3-E1 Cells: Dae Won Kim and Francis Y. Lee.Index of Contributors